U.S. Sen. Ron Johnson (R-Wis.) is asking the company that manages the U.S. Department of Defense’s Defense Medical Epidemiology Database to turn over records after the company failed to fully comply with a previous request seeking information about its “awareness of potential data problems” with the military’s database.
This is the second time Johnson has requested the records from Unissant Inc.
Johnson’s office previously sent three letters to the DOD following allegations by DOD whistleblowers that the DMED showed significant increases in registered medical diagnoses in 2021 following the authorization of COVID-19 vaccines and implementation of the DOD’s vaccine mandate.
The DMED is the military’s longstanding epidemiological database of service members.
Claiming the DMED data for 2016-2020 was incorrect, the DOD temporarily disabled the database — after whistleblowers came forward — then updated it with accurate figures, which resulted in less of an increase in medical conditions that potentially could be related to the vaccines.
The DOD said the DMED system was taken offline to “identify and correct the root cause of the data corruption.”
Given what Johnson said was the DOD’s lack of transparency, the senator asked his staff to contact Unissant to discuss its “awareness of potential data problems in DMED.”
Johnson, a ranking member of the Permanent Subcommittee on Investigations, first sent a formal letter to Unissant on March 7, requesting records related to its management of the DMED.
Unissant responded by stating it was prohibited from answering Johnson’s questions or “providing any details about the work it performs for the Defense Health Agency.”
Johnson’s staff provided Unissant with information from the DOD stating the company did not need the DOD’s consent to answer questions from Congress. A DOD contracting officer informed Unissant that “when it comes to Congressional or Senatorial inquiries, you don’t need my permission” to respond.
Despite approval to release information to Johnson’s office, Unissant requested written approval from its DOD contracting officer to release the information.
“Our letter explains why we are making this request even though you’ve stated we do not need your permission,” the email stated.
The DOD on May 2 gave Unissant permission to provide responsive documents to Johnson’s initial March 7 request, but Unissant’s letter detailing why it needed the DOD’s written permission was omitted from the records provided to his office.
“The records Unissant has provided to date as well as the company’s unclear explanation for requesting DOD’s approval to respond to Congressional inquiries raise additional questions,” Johnson said in a June 14 letter to Kenneth Bonner, president and chief growth officer of Unissant.
Johnson asked Unissant to provide the following additional information no later than June 28.
1. Does Unissant agree with DOD’s claim that “the data in DMED was corrupt for the years 2016-2020 when accessed after September 2021?” If so, please explain why the DMED data for registered diagnoses of certain medical conditions from 2016-2020 was incorrect.
2. Please explain why registered diagnoses of myocarditis in 2021 decreased from 1,239 registered cases as of August 29, 2021, to 273 registered cases as of January 10, 2022. Please explain why the average annual registered diagnosis of myocarditis from 2016-2020 increased from 216 as of August 29, 2021, to 559 as of January 10, 2022.
3. Unissant claimed that on February 10, 2022, DOD discovered the need to “fix DMED monthly data for 2021.” However, emails produced by Unissant show that on Jan. 31, 2022, Unissant’s Vice President Stephen Gehring wrote that, “the team worked over the weekend to identify and resolve the issues” with DMED. Later that day, a DOD employee confirmed that “DMED access was restored after the data was corrected.”
Did Unissant identify the issues discussed on January 31, 2022, in its list of issues relating to DMED (see enclosure)? Were the issues discussed on January 31, 2022, different from the issue identified on February 10, 2022? Did DOD or Unissant discover the issues discussed on January 31, 2022? Please provide all communications showing this.
It does not appear that Unissant provided communications referring or relating to the DMED issue discovered on February 10, 2022 (as requested in the March 7, 2022 letter). Please provide those documents.
4. Provide a list of communications and documents discussing the “need to fix DMED monthly data for 2021” and the communications relating to the DMED issues discovered on Feb. 10, 2022, that Unissant failed to disclose with the previous request.
5. On January 31, 2022, Unissant Vice President Stephen Gehring noted that his team had “worked over the weekend to identify and resolve the issues” with DMED. He added that “the team uncovered other findings in testing that need to be addressed.” What were those “other findings”? Did those finding [sic] relate to issues with DMED? If so, were those findings identified in Unissant’s chart regarding issues relating to DMED (pursuant to the March 7, 2022 letter)?
If these findings were not identified, please provide a description of those findings, when Unissant communicated those findings to DOD, and the status of any corrective action(s).
6. In a March 3, 2022 email provided by Unissant, a Unissant representative informed Unissant officials Kenneth Bonner and Stephen Gehring that as recently as August 2021, DOD and Unissant were aware of problems with DMED but still let it “go live” with those problems. What were the problems? Why did Unissant allow DMED to “go live” if it knew it had problems?
7. On April 22, 2022, Unissant’s President Kenneth Bonner attached a letter to an email to DOD Contracting Officer Kevin Hodge regarding DOD’s permission to release information to Sen. Johnson. This attachment was not included in Unissant’s May 4, 2022 production. Please provide this letter.
8. Unissant’s May 4, 2022 production included several emails between the company’s representatives and DOD officials regarding DMED issues in August 2021. It does not appear those issues were identified in Unissant’s production Exhibit 3 or Exhibit 4 (enclosed). What were those issues, who discovered those issues and when, how long did those issues exist in DMED and when were those issues corrected?
9. Unissant’s May 4, 2022 response noted that because its employees use DOD email addresses to communicate with DOD employees referring or relating to DMED, “Unissant does not have access to these documents and communications.” Does Unissant not maintain records of its employees’ communications between and among Unissant and DOD employees regarding their contracted work?
When performing work on behalf of the federal government, how does Unissant ensure that its employees are following federal record preservation requirements if Unissant cannot access its employees’ documents and communications?
DOD changes DMED data on myocarditis after whistleblowers come forward
I have been watching Sen. Johnson – love his tenacity… He will end up president if he isn’t careful!
Deb, I honestly think he has more ability to impact the system from his current position. If you don’t toe the line as president, they shoot you.